Hunan Cihui Medical Technology Co., Ltd.

Established in September 2014, Hunan Cihui Medical Technology Co., Ltd. is located in Haiping Medical Device Industrial Park, High-tech Zone, Changsha City, with a registered capital of RMB10.01 million yuan. It is a modern medical technology enterprise integrating research and development, manufacturing, sales and service. Relying on strong research and development teams, first-class production technique, advanced production equipment, and high-quality professional and technical personnel, the Company adheres to the business philosophy of "Be compassionate and create brilliance" and is committed to providing traditional Chinese medicine acupuncture products and various medical consumables for civilian markets as well as medical markets. Its main products include intelligent traditional Chinese medicine moxibustion beds, sandwiched moxibustion, governor moxibustion, thunder-fire moxibustion and other types of moxibustion materials, Healthy antibacterial solution and dozens of varieties. The product market covers all provinces, cities, and autonomous regions across the country, and enters the international market.

• The Company sticks to the principle of people-oriented, market-oriented and advocating innovation, and has obtained a batch of achievements with independent intellectual property rights in the research and development of medical products, including 3 invention patents, 25 utility model patents, 12 design patents, and one software copyright. The Company won the "Gazelle Enterprise" of Changsha High-tech Zone in 2018, and was rated as the "Enterprise with Most Market Potential" in Lianzhong Provincial Pharmaceutical Device Channel Matching Meeting in 2019.

• Since the outbreak of novel coronavirus pneumonia, the Company passed on its love for the epidemic-stricken areas, and shouldered the corporate social responsibility. It has made full efforts to produce by resuming work in advance, urgently allocated materials, added more intelligent production lines, expanded production capacity, and donated nearly 2 million of the antibacterial products for the first-line medical institutions such as Wuchang charity.